Skip Navigation

Lupus Research Alliance

PhD

Driving Progress in Lupus Research: Highlights from the Lupus Research Alliance 2025 Forum for Discovery

December 9, 2025

LRA’s annual meeting brings together global leaders to accelerate breakthroughs in lupus The 2025 Lupus Research Alliance (LRA) Forum for...

Lupus Research Alliance Grants Inaugural Awards to 11 Researchers Focused on Engineered Cell Therapies for Lupus

2025 Targeted Research Program on Engineered Cell Therapies for Lupus (TRP-ECT) Awardees

The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on...

Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy

The Lupus Research Alliance (LRA) announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The...

LRA Announces Partners on the First Anniversary of the Lupus Landmark Study

The Lupus Research Alliance (LRA) and its clinical research affiliate Lupus Therapeutics (LT) are pleased to announce the group...

Recent Discoveries Shedding Light on Why Women Are at a Greater Risk for Lupus

Lupus is a complex autoimmune disease affecting millions worldwide with a staggering gender imbalance -- about 9 of 10...

Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award

February 28, 2024

The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award...

Lupus Research Alliance Awards $3 Million to Advance Pediatric Lupus Nephritis Diagnosis and Treatment

The Lupus Research Alliance (LRA) is pleased to announce that the 2023 Global Team Science Award (GTSA) has been...

To Increase Diversity in Lupus Clinical Research, Project CHANGE Launches Pilot Programs in Atlanta, Nashville, and Philadelphia

NEW YORK, NY, June 29, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, launched...

Lupus Research Alliance Appoints New Executive Vice President of Clinical Research Affiliate Lupus Therapeutics

NEW YORK, NY. January 17, 2023— The Lupus Research Alliance (LRA) announced the appointment of Stacie J. Bell, PhD...

Lupus Research Alliance Announces 2022 Dr. William E. Paul Distinguished Innovator Awards Investigating Harmful Immune T Cells

NEW YORK, NY, Dec. 14, 2022. The Lupus Research Alliance (LRA) proudly announces the two outstanding recipients of the...

Saluting Women Shaping LRA’s Strategic Scientific Direction

March 8, 2022 In honor of Women’s History Month, the LRA is saluting the three exceptional women who serve on...

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY....